0000950170-24-071533.txt : 20240610
0000950170-24-071533.hdr.sgml : 20240610
20240610193936
ACCESSION NUMBER: 0000950170-24-071533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ceesay Abraham
CENTRAL INDEX KEY: 0001722140
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42121
FILM NUMBER: 241034330
MAIL ADDRESS:
STREET 1: C/O SCPHARMACEUTICALS, INC.
STREET 2: 2400 DISTRICT AVENUE SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rapport Therapeutics, Inc.
CENTRAL INDEX KEY: 0002012593
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880724208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 857-321-8020
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02215
4
1
ownership.xml
4
X0508
4
2024-06-06
0002012593
Rapport Therapeutics, Inc.
RAPP
0001722140
Ceesay Abraham
RAPPORT THERAPEUTICS, INC.
1325 BOYLSTON STREET, SUITE 401
BOSTON
MA
02215
true
true
false
false
Chief Executive Officer
false
Stock Option (Right to Buy)
17
2024-06-06
4
A
false
530647
0.00
A
2034-06-05
Common Stock
530647
530647
D
25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Cheryl Gault, Attorney-in-Fact
2024-06-10